Bristol-Myers Squibb Co Investor Event to Discuss Data Presented at ASCO Transcript
Good afternoon. This is Tim Power from IR at Bristol-Myers. Welcome to our investor event at ASCO 2021. And as you have seen, we had some important data from our oncology pipeline presenters over the weekend, including for our next-generation I-O agent, relatlimab. So there's a lot to cover today in a short time. And I'm joined for today's discussion by Samit Hirawat, our Chief Medical Officer; and by Chris Boerner, our Chief Commercialization Officer. Samit and Chris will go through the slide presentation and then will be available for Q&A at the end. If we can go to our next slide, which contains our forward-looking statement. I'll hand over on Slide 3 to Samit to get the presentation started.
Thank you, Tim, and good afternoon, everyone. I'm happy to have this opportunity to discuss the data presented from our pipeline at this year's ASCO meeting, which is of course a very
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
